טוען...
ENDPOINTS AND CLINICAL TRIAL DESIGN FOR NONALCOHOLIC STEATOHEPATITIS
Nonalcoholic fatty liver disease (NAFLD) is a common cause of chronic liver disease in the general population. Nonalcoholic steatohepatitis (NASH), the aggressive form of NAFLD, is associated with an increased risk of liver-related mortality and cardiovascular disease. Currently, a liver biopsy is t...
שמור ב:
| Main Authors: | , , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2011
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4014460/ https://ncbi.nlm.nih.gov/pubmed/21520200 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hep.24376 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|